Related Experiment Video
Updated: May 26, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
The cardiovascular effects of bromocriptine in Parkinsonism
J K Greenacre1, P F Teychenne, A Petrie
1Departments of Medicine (Neurology) and Clinical Pharmacology, Royal Postgraduate Medical School, Du Cane Road, London W12 0HS.
Abstract:
The cardiovascular effects of bromocriptine, a dopamine receptor agonist, were investigated in twenty-eight Parkinsonian patients. Bromocriptine caused a significant impairment of postural compensation with a fall in systolic pressure and an absence of the rise in diastolic pressure after standing for 1 min when patients taking active drug were compared to the same patients on placebo. The hypotensive effect persisted for at least 6 weeks of treatment. There was also a significant reduction in supine heart rate. One patient had marked falls in supine and erect blood pressure after a single oral dose of bromocriptine (2.5 mg) and a further patient developed paroxysmal atrial tachyarrhythmias. Both blood pressure and heart rate changes reversed spontaneously after stopping bromocriptine. It is proposed that dopaminergic mechanisms either in the central nervous system or the periphery contribute to cardiovascular regulation in man.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Alterations in Muscle Tone lll
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology